Zerbaxa 1 g/0,5 g Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Recall
|
Medicines
|
18/12/2020
The marketing authorization holder informed its customers on December 17, 2020 that due to potential microbiological contamination the listed batches are recalled as a precautionary measure.
| Name of the medicinal product | Zerbaxa 1 g/0,5 g Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | EU/1/15/1032/001 |
| CIP code | 4225279 |
| Marketing authorisation holder | Merck Sharp & Dohme B.V. |
| Batch number(s) | Batch, Expiry Date S040223, 12.2021 S041248, 12.2021 T003814, 12.2021 T004275, 02.2022 T008945, 02.2022 T025193, 06.2022 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3389 |
Further inquiry note
Page last modified:
18/12/2020